Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart J Pocock

Showing results (281-290 of 349) with videos related to

Pageof 35
Sort By:
European Heart Journal. Cardiovascular Pharmacotherapy|November 2, 2020
The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid, diabetes, and antithrombotic trialsHeinz Drexel, Basil S Lewis, Giuseppe M C Rosano, et al.
European Journal of Heart Failure|March 28, 2023
Health status across major subgroups of patients with heart failure and preserved ejection fractionTariq Jamal Siddiqi, Stefan D Anker, Gerasimos Filippatos, et al.
JAMA|December 7, 2007
Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trialGregg W Stone, James H Ware, Michel E Bertrand, et al.
Revista Espanola De Cardiologia (English Ed.)|June 16, 2018
The Usefulness of the MEESSI Score for Risk Stratification of Patients With Acute Heart Failure at the Emergency DepartmentÒscar Miró, Xavier Rosselló, Víctor Gil, et al.
Journal of the American College of Cardiology|November 17, 2012
The effect of age on outcomes of coronary artery bypass surgery compared with balloon angioplasty or bare-metal stent implantation among patients with multivessel coronary disease. A collaborative analysis of individual patient data from 10 randomized trialsMarcus Flather, June-Wha Rhee, Derek B Boothroyd, et al.
European Journal of Preventive Cardiology|October 1, 2025
Association of Neutrophil-to-Lymphocyte Ratio With Clinical Outcomes After Percutaneous Coronary InterventionAngelo Oliva, Birgit Vogel, Samantha Sartori, et al.
Journal of the American College of Cardiology|June 16, 2026
Population Prevalence of Valvular Heart Disease in the United States: The PREVUE-VALVE StudyMichael I Brener, Michael L Chuang, Raphael Nishimura, et al.
European Heart Journal|January 25, 2015
Differing prognostic value of pulse pressure in patients with heart failure with reduced or preserved ejection fraction: results from the MAGGIC individual patient meta-analysisColette E Jackson, Davide Castagno, Aldo P Maggioni, et al.
American Heart Journal|June 6, 2023
Rationale and design of a randomized study comparing the Watchman FLX device to DOACs in patients with atrial fibrillationSaibal Kar, Shephal K Doshi, Mohamad Alkhouli, et al.
Circulation|November 15, 2021
Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved TrialJaved Butler, Gerasimos Filippatos, Tariq Jamal Siddiqi, et al.
Pageof 35

Showing results (281-290 of 349) with videos related to

Sort By:
Pageof 35
European Heart Journal. Cardiovascular Pharmacotherapy|November 2, 2020
The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid, diabetes, and antithrombotic trialsHeinz Drexel, Basil S Lewis, Giuseppe M C Rosano, et al.
European Journal of Heart Failure|March 28, 2023
Health status across major subgroups of patients with heart failure and preserved ejection fractionTariq Jamal Siddiqi, Stefan D Anker, Gerasimos Filippatos, et al.
JAMA|December 7, 2007
Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trialGregg W Stone, James H Ware, Michel E Bertrand, et al.
Revista Espanola De Cardiologia (English Ed.)|June 16, 2018
The Usefulness of the MEESSI Score for Risk Stratification of Patients With Acute Heart Failure at the Emergency DepartmentÒscar Miró, Xavier Rosselló, Víctor Gil, et al.
Journal of the American College of Cardiology|November 17, 2012
The effect of age on outcomes of coronary artery bypass surgery compared with balloon angioplasty or bare-metal stent implantation among patients with multivessel coronary disease. A collaborative analysis of individual patient data from 10 randomized trialsMarcus Flather, June-Wha Rhee, Derek B Boothroyd, et al.
European Journal of Preventive Cardiology|October 1, 2025
Association of Neutrophil-to-Lymphocyte Ratio With Clinical Outcomes After Percutaneous Coronary InterventionAngelo Oliva, Birgit Vogel, Samantha Sartori, et al.
Journal of the American College of Cardiology|June 16, 2026
Population Prevalence of Valvular Heart Disease in the United States: The PREVUE-VALVE StudyMichael I Brener, Michael L Chuang, Raphael Nishimura, et al.
European Heart Journal|January 25, 2015
Differing prognostic value of pulse pressure in patients with heart failure with reduced or preserved ejection fraction: results from the MAGGIC individual patient meta-analysisColette E Jackson, Davide Castagno, Aldo P Maggioni, et al.
American Heart Journal|June 6, 2023
Rationale and design of a randomized study comparing the Watchman FLX device to DOACs in patients with atrial fibrillationSaibal Kar, Shephal K Doshi, Mohamad Alkhouli, et al.
Circulation|November 15, 2021
Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved TrialJaved Butler, Gerasimos Filippatos, Tariq Jamal Siddiqi, et al.
Pageof 35